Table 1

Comparison between the current ablation modalities.

 Thermal energyNon-thermal energy
CBARFAPFA
MechanismFreezingHeatingElectric current generation
CharacteristicsThermal cell damageThermal cell damageNon-thermal cell damage
Tissue selectivityNonselectiveNonselectiveSelective
Catheters footprintBalloonBalloon & Point-by-pointDifferent footprints
Time to ablation effectTime-needed thermal effectTime-needed thermal effectInstant electroporation
Patient preparationDeep sedation or GADeep sedation or GADeep sedation or GA
FluoroscopyMajority neededMajority neededNeeded
3-D mapping integrationNoYesWith or without
First pass PVI> 98%98%~100%
Ablation time+++++
Single-shot isolation++++
Ablation beyond PVsNoYesPossible
Adjacent tissue damage*YesYesNo
Pericardial injuryRare+No
Esophageal fistulaNo+No
Phrenic nerve palsy+ (usually transient)RareNo
Coronary artery injuryNoPossible+ (spasm with pentaspline)
HemolysisNoNoPossible
Durability at 1 year60–73%70–90%70–90%
 Thermal energyNon-thermal energy
CBARFAPFA
MechanismFreezingHeatingElectric current generation
CharacteristicsThermal cell damageThermal cell damageNon-thermal cell damage
Tissue selectivityNonselectiveNonselectiveSelective
Catheters footprintBalloonBalloon & Point-by-pointDifferent footprints
Time to ablation effectTime-needed thermal effectTime-needed thermal effectInstant electroporation
Patient preparationDeep sedation or GADeep sedation or GADeep sedation or GA
FluoroscopyMajority neededMajority neededNeeded
3-D mapping integrationNoYesWith or without
First pass PVI> 98%98%~100%
Ablation time+++++
Single-shot isolation++++
Ablation beyond PVsNoYesPossible
Adjacent tissue damage*YesYesNo
Pericardial injuryRare+No
Esophageal fistulaNo+No
Phrenic nerve palsy+ (usually transient)RareNo
Coronary artery injuryNoPossible+ (spasm with pentaspline)
HemolysisNoNoPossible
Durability at 1 year60–73%70–90%70–90%

*Vessels, nerves, esophagus

Abbreviations: CBA, cryoballoon ablation; FDA, Food and Drug Administration; GA, general anesthesia; PFA, pulsed-field ablation; PVI, pulmonary vein isolation; PVs, pulmonary veins; RFA, radiofrequency ablation.

Table 1

Comparison between the current ablation modalities.

 Thermal energyNon-thermal energy
CBARFAPFA
MechanismFreezingHeatingElectric current generation
CharacteristicsThermal cell damageThermal cell damageNon-thermal cell damage
Tissue selectivityNonselectiveNonselectiveSelective
Catheters footprintBalloonBalloon & Point-by-pointDifferent footprints
Time to ablation effectTime-needed thermal effectTime-needed thermal effectInstant electroporation
Patient preparationDeep sedation or GADeep sedation or GADeep sedation or GA
FluoroscopyMajority neededMajority neededNeeded
3-D mapping integrationNoYesWith or without
First pass PVI> 98%98%~100%
Ablation time+++++
Single-shot isolation++++
Ablation beyond PVsNoYesPossible
Adjacent tissue damage*YesYesNo
Pericardial injuryRare+No
Esophageal fistulaNo+No
Phrenic nerve palsy+ (usually transient)RareNo
Coronary artery injuryNoPossible+ (spasm with pentaspline)
HemolysisNoNoPossible
Durability at 1 year60–73%70–90%70–90%
 Thermal energyNon-thermal energy
CBARFAPFA
MechanismFreezingHeatingElectric current generation
CharacteristicsThermal cell damageThermal cell damageNon-thermal cell damage
Tissue selectivityNonselectiveNonselectiveSelective
Catheters footprintBalloonBalloon & Point-by-pointDifferent footprints
Time to ablation effectTime-needed thermal effectTime-needed thermal effectInstant electroporation
Patient preparationDeep sedation or GADeep sedation or GADeep sedation or GA
FluoroscopyMajority neededMajority neededNeeded
3-D mapping integrationNoYesWith or without
First pass PVI> 98%98%~100%
Ablation time+++++
Single-shot isolation++++
Ablation beyond PVsNoYesPossible
Adjacent tissue damage*YesYesNo
Pericardial injuryRare+No
Esophageal fistulaNo+No
Phrenic nerve palsy+ (usually transient)RareNo
Coronary artery injuryNoPossible+ (spasm with pentaspline)
HemolysisNoNoPossible
Durability at 1 year60–73%70–90%70–90%

*Vessels, nerves, esophagus

Abbreviations: CBA, cryoballoon ablation; FDA, Food and Drug Administration; GA, general anesthesia; PFA, pulsed-field ablation; PVI, pulmonary vein isolation; PVs, pulmonary veins; RFA, radiofrequency ablation.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close